Potential Biomarkers and Therapeutic Targets of Non-Small Cell Lung Cancer.

Authors

Yu Wei (ORCID: https://orcid.org/0000-0001-5894-8206)
Baolin Qu (ORCID: https://orcid.org/0000-0002-8911-3460)
Na Ma (ORCID: https://orcid.org/0000-0002-7045-6623)
Lei Xiao (ORCID: https://orcid.org/0000-0002-0428-1749)
Wei Yang (ORCID: https://orcid.org/0000-0001-7333-9652)
Lehui Du

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Yu Wei, Baolin Qu, Na Ma, Lei Xiao et al.

Nov 25, 2025

PubMed

Lung Cancer Treatments and Mutations

article

Yu Wei, Baolin Qu, Na Ma, Lei Xiao, Wei Yang, Lehui Du

November 25, 2025article en

No abstract available for this paper.

PubMed

Chinese PLA General Hospital (CN), Beihang University (CN)

Openalex Percentile: Top 45%

Lung Cancer Treatments and Mutations

AI Navigator

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Potential Biomarkers and Therapeutic Targets of Non-Small Cell Lung Cancer. — Yu Wei, Baolin Qu, et al. · PubMed (2025) | TGRS Research Map | TGRS